Abbonarsi

AsthmaMap: An interactive knowledge repository for mechanisms of asthma - 04/03/21

Doi : 10.1016/j.jaci.2020.11.032 
Alexander Mazein, PhD a, b, c, , Olga Ivanova, MSc a, d, e, Irina Balaur, PhD a, Marek Ostaszewski, PhD c, Valeriya Berzhitskaya, PhD f, Tatiana Serebriyskaya, PhD f, Thomas Ligon, PhD g, Jan Hasenauer, PhD h, i, Bertrand De Meulder, PhD a, Rupert W. Overall, PhD j, k, Ludovic Roy, MSc a, Richard G. Knowles, PhD l, Craig E. Wheelock, PhD m, Sven-Erik Dahlen, MD, PhD n, Kian Fan Chung, MD o, Ian M. Adcock, PhD o, Graham Roberts, DM p, q, Ratko Djukanovic, MD r, s, Johann Pellet, MSc a, Piotr Gawron, PhD c, Rudi Balling, PhD c, Anke H. Maitland-van der Zee, PharmD, PhD e, Reinhard Schneider, PhD c, Peter J. Sterk, MD e, Charles Auffray, PhD a
the

U-BIOPRED Study Group,

the

eTRIKS Consortium

a European Institute for Systems Biology and Medicine, Université de Lyon, Lyon, France 
b Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow, Russia 
c Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg 
d Vrije Universiteit Amsterdam, Amsterdam, The Netherlands 
e Respiratory Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands 
f Moscow Institute of Physics and Technology, Dolgoprudny, Moscow, Russia 
g Faculty of Physics and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität, Munich, Germany 
h Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany 
i Faculty of Mathematics and Natural Sciences, University of Bonn, Endenicher, Bonn, Germany 
j Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany 
k German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany 
l Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom 
m Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden 
n Unit for Experimental Asthma and Allergy Research, Institute of Environmental Medicine (IMM), Karolinska Institutet, Solna, Sweden 
o National Heart & Lung Institute, Imperial College London, London, United Kingdom 
p Clinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom 
q NIHR Southampton Biomedical Research Centre, Southampton, United Kingdom 
r Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University of Southampton, Southampton, United Kingdom 
s NIHR Southampton Respiratory Biomedical Research Unit, Southampton University Hospital, Southampton, United Kingdom 

Corresponding author: Alexander Mazein, PhD, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 6 Avenue du Swing, L-4367 Belvaux, Luxembourg.Luxembourg Centre for Systems BiomedicineUniversity of Luxembourg6 Avenue du SwingBelvauxLuxembourgL-4367
Il testo completo di questo articolo è disponibile in PDF.

Key words : Asthma, disease mechanisms, disease map, knowledge representation, data interpretation


Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Disclosure of potential conflict of interest: S.-E. Dahlen reports personal fees from AstraZeneca, Boehringer-Ingelheim, Cayman Chemicals, GlaxoSmithKline (GSK), Novartis, Regeneron, Roche, Sanofi, and Teva outside the submitted work. K. F. Chung has received honoraria for participating in advisory board meetings of GSK, AstraZeneca, Roche, Novartis, Merck, BI, TEVA, and Shionogi regarding treatments for asthma, chronic obstructive pulmonary disease, and chronic cough and has also been remunerated for speaking engagements. R. Balling is a founder and a shareholder of MEGENO S.A. and a shareholder of ITTM S.A. R. Djukanovic reports receiving fees for lectures at symposia organized by Novartis, AstraZeneca, and TEVA; consultation for TEVA and Novartis as member of advisory boards; participation in a scientific discussion about asthma organized by GSK; and is a cofounder and current consultant and has shares in Synairgen, a University of Southampton spin-out company. A. H. Maitland-van der Zee reports grants and personal fees from Boehringer Ingelheim and GSK, grants from Vertex, and personal fees from AstraZeneca, all paid to her institution, and, in a public-private partnership, sponsored by Health Holland matching grants from Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, Philips, Quantib-U, Smartfish, SODAQ, Thirona, TopMD, and Novartis outside the submitted work. R. Schneider is a founder and a shareholder of MEGENO S.A. and ITTM S.A. P. J. Sterk is a scientific adviser and officially has a nonsubstantial interest in the start-up company Breathomix BV, which produces eNoses and accompanying cloud algorithms. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 3

P. 853-856 - marzo 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • News Beyond Our Pages
  • Marc E. Rothenberg, Jean Bousquet
| Articolo seguente Articolo seguente
  • Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies
  • Matthew T. Patrick, Haihan Zhang, Rachael Wasikowski, Errol P. Prens, Stephan Weidinger, Johann E. Gudjonsson, James T. Elder, Kevin He, Lam C. Tsoi

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.